“…These diverse models impinge upon a wide array of anxiety [35,48,84,107–109,112,120,125,142–149] and despair‐like behaviors [35,48,61,108,109,125,143,146,148,150–152] and also impact cognition [22,35,65,73,149,152–154], fear conditioning [35,110–112,152,155], social interaction [35,61,115,116,156–158], sensorimotor gating [38,59,60,91,93], and hallucinogen‐evoked 5‐HT 2A R‐mediated HTR [67,113,114]. Among the GPCRs reported to be dysregulated in these models of early adversity are the Gq‐, Gi‐, and Gs‐coupled receptors involved in the signaling downstream of monoamines such as serotonin (5‐HT 1A R, 5‐HT 2A R, 5‐HT 7 R) [26,38,49,67,73–78,83,84,100,107,109,110,113–115,117,120,125,146,147,149,150,159,160], DA (D 1 R, D 2 R, D 3 R, D 4 R, D 5 R) [31,101,161–164], and norepinephrine (α 2 AR, β 3 AR) [117,155], glutamate (mGluR 2 , mGluR 4 ) [38,59,60,85,91,93,113,117,151,161,165–167], endocannabinoids (CB 1 R) [21,63,162,168], and acetylcholine (M 1 ) [62], and CRFR 1 , CRFR 2 [22,37,64,84,112,142,145,154,158,169–174].…”